Research Article
Differential Proteome Profiling Using iTRAQ in Microalbuminuric and Normoalbuminuric Type 2 Diabetic Patients
Table 2
Selected 10 differentially excreted proteins related to pathogenic status in microalbumiuric versus normoalbuminuric urines.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
aThe numbers of unique peptides and MS/MS spectrum observed by ProteinPilot software were determined only for those peptides with ≥95% confidence. bAccession numbers represent entries in the Human CDS database (human KBMS 5.0, 2005-03-02; a total of 187,748 entries provided by Applied Biosystems). cGene name from the Expasy database correspond to protein accession number bfrom the Human CDS database (human KBMS 5.0, 2005-03-02; a total of 187,748 entries provided by Applied Biosystems). d–fRatio of differentially excreted protein for iTRAQ, 2-DE and WB in microalbumiuric versus normoalbuminuric urines, respectively. |